◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Home › All stocks › A › ABBOTINDIA

Abbott India Limited (ABBOTINDIA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Abbott India Limited (ABBOTINDIA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 3,679 employees. Its market capitalization is roughly ₹579 billion. In the fiscal year ended 2026-03-31, ABBOTINDIA reported ₹69.3B in revenue and ₹15.5B in net income.

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India.

Interactive charts & full statements →

ABBOTINDIA Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-31
Total Revenue₹69.3B₹64.1B₹58.5B₹53.5B
Gross Profit₹32.2B₹29.0B₹26.1B₹23.6B
Operating Income (EBIT)₹18.2B₹16.4B₹14.1B₹11.5B
Net Income₹15.5B₹14.1B₹12.0B₹9.5B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABBOTINDIA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-30
Total Revenue₹18.1B₹17.1B₹17.2B₹17.6B₹17.4B
Gross Profit₹8.8B₹8.0B₹8.2B₹8.2B₹8.0B
Operating Income (EBIT)₹5.0B₹4.6B₹4.4B₹4.8B₹4.3B
Net Income₹4.3B₹3.9B₹3.8B₹4.2B₹3.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABBOTINDIA Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(₹10.1B)(₹8.7B)(₹6.9B)(₹5.8B)—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABBOTINDIA Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-31
Total Assets₹65.0B₹59.2B₹51.9B₹45.6B
Total Liabilities₹17.3B₹16.8B₹14.9B₹13.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABBOTINDIA viewer.

ABBOTINDIA Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ABBNAll “A” companiesABBV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.